Related Experiment Video
Updated: May 10, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Newborn Screening: Advances, Challenges, and Future Directions
Yishay Ben-Moshe1, V Reid Sutton1
1Department of Molecular & Human Genetics, Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
Insights
Newborn screening (NBS) detects rare newborn conditions early. This public health program faces challenges like access disparities and ethical concerns, but remains vital for early intervention.
Area of Science:
- Public Health
- Genetics
- Pediatrics
Background:
- Newborn screening (NBS) is a crucial public health initiative in the U.S.
- It targets early detection and management of rare, treatable congenital disorders.
- The program screens for metabolic, endocrine, and hematologic conditions, among others.
Purpose of the Study:
- To provide a comprehensive overview of the history and evolution of NBS.
- To discuss the current state of NBS, including methods, interpretation, and controversies.
- To explore future directions, particularly genomic screening in NBS.
Main Methods:
- Literature review of NBS history, milestones, and evolution.
- Analysis of current laboratory methods and clinical interpretation standards.
- Discussion of persistent challenges and future trends in NBS.
Main Results:
- NBS has evolved significantly, incorporating advanced laboratory techniques.
- The program is cost-effective and lifesaving but faces challenges.
- Key challenges include access disparities, ethical considerations, and diagnostic complexity.
Conclusions:
- NBS is a cornerstone of pediatric public health, enabling early intervention.
- Addressing disparities and ethical issues is crucial for program equity.
- Genomic screening represents a promising future trajectory for NBS.
Abstract:
Newborn screening (NBS) in the United States is a vital public health program aimed at early detection and management of rare but treatable conditions in newborns. Criteria for inclusion include the detection of numerous metabolic, endocrine, hematologic, and other conditions. While the program has proven cost-effective and lifesaving, challenges persist, including disparities in access to specialized care, ethical dilemmas surrounding patient autonomy, and the complexity of diagnosing presymptomatic conditions. This article provides an overview of the history, evolution, and current state of NBS, highlighting key milestones, laboratory methods, clinical interpretations, and controversies, while also exploring future trajectories in genomic screening.
Related Concept Videos
Current Trends in Nursing I
Steps in Outbreak Investigation
Introduction to Developmental Psychology
Three Developmental Domains
Physical Development
Physical processes, also known as maturation, encompass the biological changes that occur across an individual's life. These changes begin with genetic inheritance and continue through various stages, including growth in height and weight,...
Development of Human Microbiota
Development of the Oral Microbiota

